john sharp

Scientists expect to see preliminary results from pre-clinical trials before Oct. 1.

They say a bipartisan inquiry will be needed to learn from pandemic response failures.

Dr. Jeffrey Cirillo is leading a national team that hopes to repurpose an existing tuberculosis vaccine to fight the coronavirus. About 700 participants are needed in Texas for the clinical trial.

While the pandemic and oil glut create a double dose of devastation, three Texas A&M scholars tell Chancellor John Sharp that they see new economic opportunities rising from the rubble.

Scientists are recruiting hundreds of medical workers to test the existing vaccine's ability to mitigate the effects of the illness. Results are expected within six months.